Vaccinex, Inc.
VCNX- Exchange
- OTC
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001205922
No open-market purchases or sales by Vaccinex, Inc. insiders were filed in the last 90 days; no institution reported holding it in 13F filings for Q2 2026; no superinvestor holds it.
Q4 2021 vs. Q3 2021
How the institutions holding Vaccinex, Inc. changed between Q3 2021 and Q4 2021.
All holders in Q4 2021All holders in Q3 2021
| Measure | Q3 2021 | Q4 2021 | Change |
|---|---|---|---|
| Holders | 23 | 21 | −2 |
| Shares | 1.55M | 1.60M | +42.0K (+2.7%) |
| Value | $3.36M | $1.66M | −$1.70M (−50.6%) |
New holders (2)
Institutions that held Vaccinex, Inc. at the end of Q4 2021 but not at the end of Q3 2021.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Citadel Advisors LLC | 81,424 | $86.0K | 0.00% |
| Group One Trading, L.P. | 1,189 | $1.00K | 0.00% |
Sold out (4)
Institutions that held Vaccinex, Inc. at the end of Q3 2021 and filed for Q4 2021 without it.
| Institution | Shares, Q3 2021 | Value, Q3 2021 |
|---|---|---|
| Tacita Capital Inc | 13,574 | $29.0K |
| Royal Bank of Canada | 1,000 | $2.00K |
| Harbour Investments, Inc. | 500 | $1.00K |
| Bedel Financial Consulting, Inc. | 100 | $0 |